Proton Craniospinal Irradiation for Leptomeningeal Metastases. Read more about Proton Craniospinal Irradiation for Leptomeningeal Metastases.
A Patient With Prior Skin Cancers and New Diagnosis of Bell Palsy. Read more about A Patient With Prior Skin Cancers and New Diagnosis of Bell Palsy.
Tomosynthesis vs Digital Mammography Screening in Women with a Family History of Breast Cancer. Read more about Tomosynthesis vs Digital Mammography Screening in Women with a Family History of Breast Cancer.
Endocrine Therapy Interruption, Resumption, and Outcomes Associated With Pregnancy After Breast Cancer. Read more about Endocrine Therapy Interruption, Resumption, and Outcomes Associated With Pregnancy After Breast Cancer.
Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ: A Phase 1 Nonrandomized Clinical Trial. Read more about Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ: A Phase 1 Nonrandomized Clinical Trial.
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review. Read more about Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review.
Bilateral Mastectomy vs Lumpectomy and Breast Cancer Mortality Risk. Read more about Bilateral Mastectomy vs Lumpectomy and Breast Cancer Mortality Risk.
Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial. Read more about Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial. Read more about Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial.
MRI-Linac-Based Radiotherapy-Promising or Hype? Read more about MRI-Linac-Based Radiotherapy-Promising or Hype?
